Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03285542 · ClinicalTrials.gov registry record · NA
Prospective Randomized Trial of Dermabond Prineo in Total Knee Arthroplasty
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03285542 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants.
The verdict
NCT03285542, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
In this prospective pilot study examining the superficial closure during total knee arthroplasty, active subjects will receive the STRATAFIX Spiral Knotless Tissue Control Device for subcuticular closure in addition to DERMABOND PRINEO (Ethicon, Johnson and Johnson, Somerville, New Jersey) system for dermal closure. The control subjects will receive staples (standard-of-care).
Interventions
- DEVICE Staples
- DEVICE DERMABOND
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03285542
The ClinicalTrials.gov registry entry for NCT03285542 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Staples is the first listed.
NCT03285542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03285542 about?
NCT03285542 is a clinical study titled "Prospective Randomized Trial of Dermabond Prineo in Total Knee Arthroplasty". In this prospective pilot study examining the superficial closure during total knee arthroplasty, active subjects will receive the STRATAFIX Spiral Knotless Tissue Control Device for subcuticular closure in addition to DERMABOND PRINEO (Ethicon, Johnson and Johnson, Somerville, New Jersey) system fo...
What is the current status of trial NCT03285542?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-09-15. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03285542?
The interventions under investigation include: Staples (DEVICE), DERMABOND (DEVICE).
Who is sponsoring clinical trial NCT03285542?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.